The murine model of human cytomegalovirus infection was employed to analyse the kinetics of antibody production to murine cytomegalovirus (MCMV) structural and immediate early (IE) polypeptides following MCMV infection of genetically resistant and susceptible strains of mice. A total of 22 structural and six non-structural, IE proteins were identified. Analysis of immunoblots by densitometry identified four patterns of antibody reactivity to MCMV structural polypeptides during primary and secondary antibody responses over a period of 5 weeks post-infection (p.i.). Firstly, antibodies were strongly reactive with an 83K protein soon after infection, with levels which decreased with time; antibodies to a second group of viral proteins were also recognized soon after infection, but consistent levels of reactivity were maintained. Viral proteins that were recognized beyond day 14 p.i. or following a second MCMV infection formed the third group; the fourth group consisted of viral proteins that were detected at variable times p.i. by antisera from different mouse strains. The kinetics and intensity of the antibody response to individual viral proteins were influenced by virus dose, time p.i. and by a second MCMV infection. In addition, the genetic constitution of the host influenced the antibody response to MCMV proteins both quantitatively and qualitatively. In particular, sera from mice possessing C57BL but not BALB/c genes detected a 56K Mr viral protein during seroconversion.
INTRODUCTION
Infection of mice with murine cytomegalovirus (MCMV) has been widely used as a model for human cytomegalovirus (HCMV) because many features of the infection are similar, both in vivo and in vitro (Hudson, 1979; Osborn, 1982; Jordan, 1983; Griffiths & Grundy, 1987) . In addition, the murine model is particularly useful because it offers the opportunity to study the effect of host genetic factors on resistance to CMV infection. Both H-2-and non-H-2-1inked genes confer resistance to MCMV [Chalmer et al., 1977; Grundy (Chalmer) et al., 1981 ; , and while the mechanisms of genetic resistance are not fully understood, these genes have been shown to influence the replication of MCMV in target cells (Allan & Shellam, 1984; Harnett & Shellam, 1985; Price et al., 1987) and the efficacy of protection by both interferon [Grundy Harnett & Shellam, 1982; Quinnan & Manischewitz, 1987] and natural killer cells (Bancroft et al., 1981 ; Shellam et al., 1985) . In addition to these non-specific mechanisms, recent studies in this laboratory have shown that delayed-type hypersensitivity responses of mice to MCMV closely correlate with genetically determined 0000°8873 © 1989 SGM resistance (Lawson et al., 1987) . Antibody titres to MCMV have also been found to differ between mouse strains (Lawson et al., 1988) . Although no correlation was observed between either the titre of total or neutralizing antibodies to MCMV and host resistance, it is not known whether the genetic status of the host influences the specificity or intensity of the antibody response to individual MCMV proteins.
MCMV specifies more than 50 temporally regulated structural and non-structural proteins during the infectious cycle (Chantler & Hudson, 1978) , as does HCMV. Owing to this complexity, the MCMV proteins that stimulate protective cell-mediated or humoral immunity have not been studied in detail, although recent reports have indicated an immunodominant role in cytotoxic T cell responses for MCMV non-structural proteins synthesized at immediate early (IE) times post-infection (p.i.) (Reddehase et al., 1986; Koszinowski et al., 1987) .
Studies of HCMV infection have shown that although virtually all HCMV proteins are immunogenic (Osborn, 1982; Pereira et al., 1983) , there is extensive heterogeneity in the recognition of HCMV proteins by sera from different donors (Landini et al., 1985; Porath et al., 1987; Shimokawa et al., 1987; Gold et al., 1988) . While this may reflect antigenic variation among HCMV strains, little is known of the influence of other parameters such as viral dose, time p.i., the genetic and immune status of the host on the antibody response to individual HCMV proteins. For the immunoblot technique to be a clinically useful indicator of the development of HCMV antibodies, the influence of these parameters must be addressed.
Accordingly, the aim of this study was to characterize and compare the temporal appearance of antibodies to the structural and IE proteins of a single strain of MCMV by genetically resistant and susceptible strains of mice following MCMV infection. Furthermore, we investigated the parameters that influence the kinetics, intensity and specificity of the antibody response.
METHODS
Mice. Inbred, specific pathogen-free (SPF) 8 to 10-week-old female mice were obtained from the Animal Resources Centre (Murdoch, Western Australia) and maintained under minimal disease conditions. All mice were seronegative for MCMV prior to this study, confirming previous reports from this laboratory (Lawson et al., 1988) . The mouse strains used with their 50% lethal MCMV dose (LDso) values relative to BALB/c (arbitrarily assigned a value of 1) and their H-2 K, I, D and L haplotypes are shown in Table 1 . Wild mice (Mus domesticus) were trapped on Kerguelen Island, Southern Ocean (48 ° 15's, 69 ° 10%) and maintained under conventional conditions at the University of Western Australia. Subspecies analyses of the wild mice were determined by isoenzyme electrophoresis.
Virus stocks. The Smith strain of MCMV was maintained by salivary gland passage in weanling female BALB/c mice as described by Allan & Shellam (1984) . The infectivity of virus stocks was determined by plaque assay (Chalmer et aL, 1977) on mouse embryo fibroblasts (MEF), and is expressed as p.f.u, per ml. The inoculum of 0.3 LDs0 of MCMV for BALB/c mice (denoted 0.3 BALB/c LD50) contained 104 p.f.u.
MCMV infection and serum collection. Groups of 40 mice were inoculated intraperitoneally (i.p.) with 0.3 BALB/c LDs0 (104 p.f.u.) MCMV in buffered saline with the osmolality of mouse serum (MOBS; pH 7.2) containing 0.5 ~o foetal calf serum (FCS). Sera were collected from groups of five mice on days 4, 7, 10, 14, 18, 21, 28 and 35 p.i., and also from uninfected mice. For the studies of the secondary antibody response, 40 mice that had received the primary inoculum were challenged with the same dose 28 days later and sera were collected at the same intervals p.i.
To investigate the effect(s) of increased MCMV dose, mice received a dose of MCMV equivalent to 0.3 LDso for that mouse strain (hereafter termed a 'strain-adjusted' 0.3 LD50 dose). For example, a 0.3 LD5o dose for BALB. K mice was equivalent to 105 p.f.u, since BALB .K mice are 10 times more resistant than BALB/c to lethal MCMV infection. Sera were collected as above. Since the resistance status of wild mice was unknown, six mice seronegative for MCMV were inoculated with 103.6 p.f.u. MCMV i.p., a dose which was sublethal for all mice. As sera from these mice were required for other assays, serum from individual mice was not available. Sera from two groups of three mice were collected 28 days p.i.
Hyperimmune sera were collected from mice inoculated i.p. with 104 p.f.u. MCMV and rechallenged i.p. with 103 p.f.u. MCMV 4 and 8 weeks later. Sera were collected 14 days after the final injection, and stored at -70 °C until use.
Preparation oflE antigen. Confluent MEF (10 7.6 total cells) were infected at 1 to 4 p.f.u./cell MCMV under centrifugal enhancement conditions (30 min at 750 g) in the presence of 50 gg/ml cycloheximide (Sigma) and 2% FCS in Eagle's MEM (EMEM; Gibco) as previously described by Reddehase & Koszinowski (1984) . Following a 
• The LD50 value is compared with that of BALB/c mice which is assigned a value of 1.
3 h incubation at 37 °C, MEF monolayers were washed three times with EMEM to remove the cycloheximide, and incubated for 4 h at 37 °C with EMEM with 2~o FCS containing actinomycin D (Merck, Sharp and Dohme) at 5 p.g/ml. The MEF were then disrupted by scraping and pelleted at 500 g for 15 rain at room temperature. Cells were separated into nuclear and cytoplasmic fractions as described by Jeang & Gibson (1980) following resuspension in 1 ml lysis buffer. The cell lysate was sonicated for 10 s at 4 °C and allowed to stand on ice for 10 min. Following centrifugation at 16000 g for 3 min the nuclear pellet was resuspended in 400 ~tl lysis buffer and stored at -70 °C until required. As a control, nuclear fractions from mock-infected cells were prepared by the same procedure. For SDS-PAGE, the nuclear suspension was diluted 1 : 3 in electrophoresis sample buffer containing 2 ~ SDS and 5 2-mercaptoethanol and boiled for 3 rain.
Preparations of structural MCMV proteins for SDS-PAGE. Extracellular MCMV was harvested from MCMVinfected MEF exhibiting >75~ c.p.e. Following clarification at 1500g, the supernatant was centrifuged at 100000g for 1 h at 4 °C to pellet the virus. The virus pellet was resuspended in 5 to 7 ml MOBS and loaded onto a Bio-Gel A-15 m column (Bio-Rad) to remove proteins having an Mr less than, or equal to 15 × 106, as previously described by Kim et al. (1976) . MCMV was collected in the void volume, pelleted at 100000 g for 1 h at 4 °C, and resuspended in 1 ml of MOBS. Protein estimations were performed by the method of Bradford (1976) . For SDS-PAGE, 1 mg of MCMV protein was diluted 1:3 in electrophoresis buffer and boiled for 3 min. As controls, mockinfected MEF were treated with cell lysis buffer (Jeang & Gibson, 1980) and purified by the same procedure. This method was chosen in preference to the purification of extracellular fluid from mock-infected MEF since intracellular proteins are released from MCMV-infected cells.
SDS-PAGE.
Structural and IE MCMV proteins were separated by SDS-PAGE under reducing conditions using a discontinuous buffer system (Laemmli, 1970 Immunoblotting. Separated polypeptides were electrophoretically transferred (65 V for 16 h) to a 0.45 p-m nitrocellulose sheet (Bio-Rad) by the method described by Towbin et al. (1979) . Following transfer, the protein standards were stained with a solution containing 0.1 ~ amido black and the remaining nitrocellulose containing blotted MCMV proteins was cut into 5 mm strips. Excess protein-binding sites were blocked by incubation of the strips in MOBS with 2~ skim milk powder (MOBS/SMP) for 1 h at 37 °C. Anti-MCMV sera were diluted 1:20 in MOBS/SMP and incubated with the nitrocellulose strips for 3 h at 37 °C on a rocking platform. Following three 20 min washes with MOBS/SMP, the strips were incubated with an alkaline phosphatase-conjugated goat antimouse IgG + IgM F(ab')2 antibody (Tago) at 1 : 1000 dilution in MOBS/SMP for 2 h at 37 °C. After three washes as described above, the strips were developed with the substrate o-dianisidine (Sigma) and fl-naphthyl acid phosphate (Sigma) as described by Dao (1985) . As a standard reference, both hyperimmune and normal mouse sera were included in every immunoblot assay. Densitometry. Immunoblots were scanned using a video densitometer (Bio-Rad). The intensities of reactions between antibodies and viral proteins were quantified by integration of the peaks using a one-dimensional analyst program (Bio-Rad; developed by G. Booth, University of Leeds, U.K.). The Mr of viral proteins were determined by comparison with standards of known Mr (Bio-Rad).
RESULTS

Immunoblot characterization o f hyperimmune sera and normal mouse sera
The maximum number of M C M V structural and IE proteins which could be recognized by MCMV-specific antibodies using the immunoblot method was determined by analysing the reactivity of pooled sera from hyperimmunized BALB/c, B A L B . K , BALB.B, CBA, A/J, C57BL/10, B10. BR and B10. D2 mice (Fig. l, lanes 2 and 4) . Pooled sera from uninfected mice exhibited no reactivity to M C M V structural proteins (Fig. 1, lane 1) . In addition, no reactivity was observed by hyperimmune sera with cell lysates from mock-infected MEF (not shown). With the MCMV-infected MEF nuclear extracts, two proteins of Mr 35K and 37K were faintly detected by normal mouse sera (Fig. 1, lane 3) ; however, both proteins were also recognized by antibodies in nuclear extracts from mock-infected MEF (not shown) and therefore were designated as non-viral.
Pooled hyperimmune sera reacted with 21 structural M C M V proteins of Mr 33K to 38K, 39K, 47K, 50K, 56K, 60K, 68K, 76K, 78K, 83K, 87K, 92K, 98K, 102K, ll0K, lI5K, I18K, 120K, 123K, 138K and 144K (Fig. 2 ). Viral proteins of Mr 33K to 38K, 60K, 92K and 98K were detected by densitometry as broad, diffuse bands but all other proteins were well defined. Thus, to quantify the recognition of viral proteins by densitometry, the area beneath the peaks rather than the height of the peaks was determined for all subsequent experiments. Different levels of antibody reactivity to individual proteins were observed, with high antibody responses (area >/1-50 mm 2) to the 50K, 83K, 92K, 102K and ll0K proteins. Intermediate levels of antibody reactivity (area 0.5 to 1.5 mm 2) to the 33K to 38K, 39K, 47K, 56K, 60K, 98K, 115K and 144K proteins were observed, and reactivity to the 68K, 78K, 118K, 120K, 123K and 136K proteins was low (0.1 mm z ~ area ~ 0.5 minE). Several proteins with M~ < 25K were observed and may represent cleavage products of more slowly migrating species. The accurate Mr of these proteins is currently being determined by SDS-PAGE using higher levels of polyacrylamide. Hyperimmune sera reacted with a total of six IE MCMV proteins ( Fig. 1 and 2 ) of M~ 40K, 43K, 76K, 81K, 85K and 89K proteins. High antibody reactivity to 76K and 89K proteins was detected; antibody recognition of the 40K, 43K, 81K and 85K proteins was low.
Kinetics of the primary antibody response to MCMV structural proteins in genetically resistant
and susceptible mice The specificity and sequence of MCMV-specific antibodies from resistant (BALB.K, B10. BR and CBA) and susceptible (BALB/c, BALB. B, C57BL/10 and A/J) mice following a single challenge of l04 p.f.u. MCMV (0.3 BALB/c LDs0) was determined by immunoblotting and analysed by densitometry.
The days p.i. when antibodies reactive with MCMV polypeptides were first detected and the maximum levels of reactivity observed during seroconversion are presented in Table 2 . The MCMV proteins were categorized into four groups on the basis of the kinetics of the antibody response. Firstly, antibodies from all four mouse strains reacted with an 83K protein at day 4 or 7 p.i., the response being highest in A/J and lowest in CBA mice. Peak levels of antibody reactivity to this protein were detected by 10 to 14 days p.i. in all strains, beyond which time the intensity of the response decreased, and indeed was not detected at day 35 p.i. in C57BL/10, BALB.K and B10.BR sera.
Antibodies reactive to 50K, 98K, 102K, 110K and 115K proteins were detected in sera from most strains by day 14 p.i., and represented a second pattern of antibody recognition. Unlike the response to the 83K protein, levels of antibody reactivity to these proteins increased with time, with A/J sera exhibiting the highest response to the 50K, 98K, 110K and 115K proteins and BALB/c antisera giving the most intense reaction with the 102K protein. In contrast, antisera from BALB. B and BALB. K mice gave the lowest response to both the 50K and 98K proteins. Furthermore, BALB. B sera failed to recognize the 102K, 110K and 115K proteins. Similarly, BALB.K antisera gave no detectable reactivity with the 115K protein.
A third group of proteins consisting of 60K, 68K, 76K, and 87K species were recognized by antibodies later than day 14 p.i., with sera from only the susceptible A/J, BALB/c and BALB. B (determined by densitometric analysis of the area and intensity of staining of immunoblots). + + + +, area t> 2.5 mm z ; + + +, 1.5 mm 2 ~< area < 2-5 mm z; + +, 0.5 mm: ~< area < 1-5 mmZ; +, 0.1 mm 2 ~< area < 0-5 ram2; -, no detectable reaction.
strains reacting with the 60K and 68K proteins. Antisera from the more resistant strains gave lower responses to the 76K protein, and indeed BALB. K mice did not give a detectable antibody response to any proteins in this group. Unlike the high levels of antibody reactivity to proteins in groups one and two by most mouse strains, low to intermediate levels of antibody reactivity with group three proteins from all mouse strains were detected (0.1 mm 2 < area < 1.5 ram2).
Finally, the sequence of appearance and level of antibodies to the 33K to 38K, 39K, 47K, 56K, 92K and 144K proteins were highly variable between mouse strains. Sera from A/J mice reacted with all proteins in this fourth group, in contrast with BALB. K antisera which recognized only the 92K and 144K proteins. Similar to the response to the 60K and 68K proteins, higher levels of antibodies reactive with the 92K protein were raised by A/J, BALB/c and BALB. B mice compared with the more resistant mouse strains. Interestingly, antisera from mice possessing the BALB genotype exhibited no reactivity to the 56K protein.
Thus, a total of 16 proteins were detected by antisera following a primary response to a 0-3 BALB/c LD50 MCMV infection; no reactivity was observed to the 78K, 118K, 120K, 138K or 144K proteins which were detected by hyperimmune sera. At this dose of MCMV, no correlation was observed between the number of viral polypeptides recognized by antibodies and the resistance status of the host. However, high levels of antibody reactivity (area > 1.5 mm 2) to MCMV polypeptides were observed with antiser a from only the susceptible A/J, BALB/c, BALB.B and C57BL/10 mice.
Immunoblot studies of the secondary antibody response to MCMV polypeptides
To determine the effect of a second MCMV challenge on the polypeptides of MCMV recognized by immune sera, BALB/c, BALB. K, C57BL/10 and B10. BR mice were inoculated i.p. with 0.3 BALB/c LD5o (104 p.f.u.) MCMV 28 days after a primary inoculation of the same dose. Sera subsequently collected were assayed by immunoblotting. Analysis of immunoblots by densitometry showed higher levels of antibodies reactive with viral proteins than were recognized during the primary response in sera from all four mouse strains, but particularly by BALB. K, C57BL/10 and B10. BR antisera (Table 3) .
As observed following the primary MCMV challenge, levels of antibody recognition of the 83K protein were highest at days 4 or 7 p.i. in all sera. Thereafter, they decreased with time and Table 2 footnote).
were undetectable in BALB. K mice by day 21 p.i. In addition, no reactivity to the 56K protein was detected with BALB/c or BALB. K antisera at any time following a second MCMV challenge. However, unlike the primary antibody response, reactivity to the 60K, 68K, 76K and 87K proteins was detected in antisera from alt four mouse strains following the second MCMV challenge.
The recognition of five polypeptides was observed for the first time during the secondary response, with antisera from all four mouse strains recognizing a 78K protein at variable times • p.i. with BALB/c antisera recognizing 120K, 123K and 138K proteins day 4 p.i. Furthermore, both BALB.K and C57BL/10 antisera recognized a 180K protein during the secondary response. Reactivity to this protein by sera from B 10. BR and BALB/c mice cannot be excluded however, since this high Mr protein may not always have entered the resolving gel with every immunoblot assay.
Effect of increased MCMV dose on the kinetics and the intensity of the primary antibody response to MCMV structural polypeptides
The effect of increased virus dose was determined in the resistant B10.BR and BALB.K mice, which were challenged with a mouse strain-adjusted 0.3 LDs0 MCMV dose. As in the previous experiments, BALB/c mice were inoculated with 104 p.f.u., this dose being equivalent to 0.3 LDs0 in this strain. B10. D2 mice were included to determine the influence, if any, of the H-2 D haplotype in association with B10 background genes on the nature of the antibody response to individual MCMV proteins.
The primary antibody response to most MCMV polypeptides was detected earlier and with greater intensity by sera from resistant BALB. K and B10. BR mice following the higher virus dose (Table 4 ) compared with the lower dose ( Table 2 ). In addition, there was an increase in the number of viral polypeptides which were recognized, with BALB. K sera reacting for the first time with 120K, 123K and 138K proteins; similarly, B 10. BR sera reacted for the first time with 39K and 47K proteins. However, even at this higher virus dose, both BALB/c and BALB. K sera failed to recognize the 56K protein, unlike B10. D2 and B10. BR sera. Subsequent immunoblot Table 2 footnote). studies using sera from individual B10. D2 and B10. BR mice showed uniform reactivity to the 56K protein (not shown). Indeed, hyperimmune sera from BALB/c, BALB. K and BALB. B mice also failed to recognize this protein, whereas B10.D2, B10.BR and C57BL/10 hyperimmune sera exhibited strong recognition (not shown). Thus, in addition to the influence of the parameters of time p.i., virus dose, and secondary virus challenge, the kinetics and intensity of the antibody response to the 56K protein was also influenced by the genetic status of the host, with strong recognition being associated with C57BL background genes.
As observed previously, antibody reactivity to the 83K protein was highest at days 4 or 7 p.i. and decreased with time, indicating that antibodies to this protein are readily induced during acute MCMV infection. The 83K protein is also an immunodominant antigen following an i.p. injection of heat-killed MCMV (data not shown), indicating that the antibody response to this polypeptide does not require infection with live MCMV. In contrast, antibodies to the 118K protein were detected only in hyperimmune serum, indicating that reactivity to this protein is only induced following repeated MCMV challenges. While an increase in the number and in the intensity of the recognition of the viral proteins detected during a primary antibody response was observed following the higher virus dose, no correlation between host resistance to MCMV and the level of the antibodies reactive to individual MCMV polypeptides was observed.
Comparison of the antibody responses to structural MCMV proteins by BALB/cBy, C57BL/6JBy and recombinant inbred CXB strains
The effects of the C57BL and BALB/c genotypes on the antibody response to the 56K protein, as well as to other MCMV structural proteins, were studied using antisera from BALB/cBy, C57BL/6JBy and the seven recombinant inbred CXB mouse strains. Antisera were collected 28 days after a strain-adjusted 0-3 LDs0 MCMV i.p. challenge, at which time the antisera from all C57BL mice recognized this protein, and were assayed by immunoblotting.
Sera from C57BL/6JBy and BALB/cBy mice showed high (area > 1.5 mm 2) or negligible (area < 0.1 mm 2) responses to the 56K Mr protein respectively (Fig. 3) . High antibody responses to this protein were observed with CXBD and CXBK antisera similar to C57BL/6JBy sera, •l15K
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....... Fig. 3 . Profile of structural MCMV proteins recognized by immune sera from BALB/cBy, C57BL/6JBy and the seven recombinant inbred CXB strains. Sera from (1) BALB/cBy, (2) C57BL/6JBy, (3) CXBD, (4) CXBE, (5) CXBG, (6) CXBH, (7) CXBI, (8) CXBJ and (9) CXBK mice were collected 28 days following a 0-3 LDso MCMV i.p. challenge and analysed by immunoblotting. Proteins to which antibodies from the nine mouse strains exhibit differences in reactivity are shown (e). Mr standards are indicated.
while sera from CXBE mice showed intermediate reactivity (0.5 ~< area < 1.0). In contrast, CXBG, CXBH, CXBI and CXBJ showed negligible reactivity (0-1 m m 2 ~< area < 0-5 mm 2) to the 56K protein. This antibody response pattern was also observed with antisera from individual CXB mice and with pooled hyperimmune CXB sera (not shown). Therefore, the heterogeneity of the antibody response to this protein was not due to differences in the immunoblot pattern between individual sera or the kinetics of the primary antibody response. The strain distribution pattern (SDP) of antibody reactivity to the 56K protein in the CXB strains D, E, G, H, I, J and K was B, B, C, C, C, C and B, respectively, with B denoting the response to the 56K protein similar to sera from C57BL/6JBy mice (high or intermediate), while C denotes the BALB/cBy-like response (negligible). In addition, different levels of reactivity to 50K, 76K, 83K, 102K and 115K proteins were observed between BALB/cBy, C57BL/6By and recombinant CXB sera. However, unlike the response to the 56K protein, these differences were not observed in sera from hyperimmunized CXB mice.
To determine whether variation in the antibody recognition of the 56K protein between BALB/c and C57BL mice was due to differences in the level of expression of this polypeptide in infected cells from the BALB/c and C57BL mouse strains. M C M V was grown in M E F cultures derived from either BALB/c, B10.BR or (BALB/c x B10.BR)F1 mice under identical conditions and used as the source of MCMV structural proteins in the immunoblot assay. Antisera from either hyperimmunized BALB/c or B10. BR mice did not detect the 56K protein in the BALB/c M C M V preparation whereas B10.BR, but not BALB/c antisera strongly recognized this protein in virus preparations grown in (BALB/c × B 1 0 . B R ) F 1 and B10.BR M E F cultures (Fig. 4) . Thus, the expression of the 56K protein was a genetically dominant trait in these F1 MEF. Finally, antibody recognition of all M C M V structural proteins by both antisera was lower using BALB/c-derived M C M V as the blotting antigen compared with M C M V from (BALB/c × B 1 0 . B R ) F 1 and B10.BR MEF.
Antibody responses to structural M C M V proteins in wild mice
Differences in the level of antibodies reactive with M C M V structural polypeptides were observed with pooled serum samples from wild mice collected 28 days after an i.p. challenge of 103.6 p.f.u. M C M V (Fig. 5) . Interestingly, antibody reactivity to the 56K protein was detected by sera from one group of wild mice but not by sera from the other group. Unlike responses to M C M V by inbred mice, immune sera from wild mice showed poor reactivity to the 87K and 92K proteins. In contrast, high antibody responses to 33K to 38K, 60K and 102K proteins by both pooled sera were observed. In addition, antibodies from one group of sera reacted with the 50K and 115K proteins, while higher responses to the 144K protein were observed by the other pool of sera.
Immunoblot analysis of the antibody response to IE MCMV proteins
The presence of antibodies to IE MCMV in the sera from BALB/c, BALB. K, B10. D2 and B10. BR mice was assayed on days 7, 14, 21, 28 and 35 following a single i.p. challenge with 0-3 LD5o MCMV. As observed with hyperimmune serum to IE proteins ( Fig. 1 and 2) , antisera from all four mouse strains exhibited a strong response to an 89K protein, which was first detected at day 14 p.i. by both BALB/c and B 10. D2 anti sera and at day 21 p.i. by BALB. K and B10. BR antisera (not shown). Lower responses to 76K, 81K and 84K proteins were detected in all strains concomitant with the recognition of the 89K protein. This observation is consistent with reports that the 76K and 84K proteins are post-translational modifications of the 89K protein (Keil et al., 1985) , although whether the 81K protein is also a processed derivative of the 89K protein remains to be elucidated. No reactivity was observed to either the 40K or 43K proteins, which were recognized by hyperimmune sera. DISCUSSION A total of 22 structural proteins and six non-structural IE MCMV proteins were recognized with pooled hyperimmune sera, which is the largest number of MCMV proteins detected by the immunoblotting technique which has been described. The kinetics of antibody production to most structural and non-structural MCMV polypeptides were similar between genetically resistant and susceptible mouse strains.
Analysis of immunoblots by densitometry identified four patterns of antibody responses to structural MCMV proteins. One group of antibodies from all mouse strains reacted with an 83K MCMV protein on day 4 p.i. The intensity of the antibody response to this protein was highest between days 7 and 14 p.i. and decreased to low or undetectable levels by day 35 p.i., although antibody levels were elevated following a second MCMV challenge. Thus, strong antibody reactivity to this protein may indicate a recent MCMV infection.
Antibodies to a second group of viral proteins were also detected during the acute stages of a primary MCMV infection. However, unlike the antibody response to the 83K protein, levels of antibody reactivity to these proteins increased to day 35 p.i. A third group of proteins was recognized later than day 14 p.i. or during the secondary response. Finally, antibodies to a fourth group of proteins were detected at times p.i. which were variable between mouse strains.
These results correlate with observations of human antibody responses to HCMV infection by Gold et al. (1988) who identified four temporally determined patterns of antibody reactivity to HCMV structural proteins. Firstly, antibodies to a 125K Mr protein were detected 1 month after infection in 83~ of sera, with levels of reactivity which were decreased in the majority of patients 10 to 18 months later. Similar immunoblotting studies by Porath et al. (1987) showed reactivity of IgM and IgG antibodies to 235K and 205K HCMV proteins in acute (1 to 2 weeks p.i.), but not in convalescent (4 to 12 weeks p.i.) antisera. Secondly, antibodies to additional HCMV proteins were detected within 1 month after infection, but remained highly reactive with time; thirdly, antibodies to a discrete group of HCMV proteins were first detected 6 to 8 months after infection; finally, antibodies to a fourth group of proteins possessed specificities and kinetics that varied between patients (Gold et al., 1988) .
In the present study, MCMV proteins were detected earlier and with greater intensity following an increase in virus dose or following a second MCMV challenge. However, the effects of these parameters on the kinetics and the intensity of the human antibody response to HCMV proteins is difficult to assess. Nevertheless, antibodies from symptomatic HCMVinfected renal transplant patients have been shown to exhibit more intense reactions to individual HCMV proteins than antibodies from asymptomatic seropositive subjects (Shimokawa et al., 1987) . Furthermore, immunoprecipitates obtained with sera from symptomatic, congenitally infected children reacted with HCMV polypeptides that were not H. E. FARRELL AND G. R. SHELLAM recognized by sera from healthy, seropositive children (Pereira et al., 1982 (Pereira et al., , 1983 . Although this variability may be due to antigenic heterogeneity among HCMV strains (Gold et al., 1988) , it is also possible that virus dose, repeated viral recrudescence and host genes may influence the level of recognition of HCMV polypeptides by human immune sera. In addition to extrinsic factors, our evidence clearly indicates that the genetic constitution of the host influences the level of antibody reactivity to MCMV structural proteins (Table 2, Fig.  3 ). Immunoblotting analysis of sera from CXB recombinant inbred mice showed that responsiveness or lack of responsiveness to the 56K protein was distributed among these seven mouse strains, with CXBD, CXBE and CXBK antisera resembling the reactivity exhibited by C57BL/6JBy progenitor mouse sera and CXBG, CXBH, CXBI and CXBJ antisera exhibiting negligible antibody reactivity similar to BALB/cBy progenitor mice. The SDP among CXB mice does not correlate with in vivo resistance to MCMV in these strains (A. A. Scalzo & G. R. Shellam, unpublished observations), but closely resembles the allelic pattern for the b locus (Bailey, 1981) which is linked to the structural genes for alpha interferon (De Maeyer-Guignard et al., 1986 ). These observations suggest further studies on the linkage of the genes controlling either reactivity to or expression of the 56K MCMV protein. Analysis of immune sera from wild mice also indicated that 'responders' and 'non-responders' to the 56K protein were distributed among wild mice, and were not confined to highly inbred laboratory mouse strains. In addition, our results indicate that the host genetic constitution influences the expression of the 56K viral protein rather than the ability of the host to respond to this protein, since serum from B 10. BR mice did not detect the 56K protein in MCMV preparations from BALB/c MEF, but did detect this protein in viral preparations from B10. BR MEF. However, the antibody response to the 56K protein did not correlate with known genetically determined host resistance status to MCMV, and therefore the role of this protein in MCMV infection and the ability to evoke a protective host response remains to be elucidated. Heterogeneity in the expression of HCMV proteins among wild-type HCMV isolates and differences in the profile of human antibodies reactive with HCMV proteins have been reported (Pereira et al., 1982 (Pereira et al., , 1983 Landini et al., 1985 ; Porath et al., 1987; Shimokawa et al., 1987; Gold et al., 1988 ), but it is not known whether these differences have a host genetic basis. Identification of HCMV proteins which are immunogenic for all individuals is required for the development of appropriate monoclonal antibodies for the diagnosis of CMV infection and for the future development of a subunit vaccine. The differences observed in the level of antibody recognition of IE MCMV proteins between mouse strains support the observations of Blanton & Tevethia (1981) of varying reactivities for HCMV IE and early polypeptides with different human sera. The presence of antibodies against HCMV IE and early antigens has been associated with an active HCMV infection Gerna et al., 1978; Musiani et al., 1978) , although subsequent reports have provided evidence to the contrary (Friedman et al., 1982) . In the present study, antibodies to IE antigens of MCMV in mouse sera were first detected as late as 3 weeks p.i. and were also present in sera from hyperimmunized mice. Since replication and dissemination of MCMV in all susceptible organs (except the salivary gland) occurs within the first 2 weeks following infection and then rapidly subsides (Allan & Shellam, 1984) , our studies confirm reports that antibody production to IE MCMV proteins does not necessarily coincide with acute MCMV infection. In addition, recent in vitro evidence has shown that concomitant with the expression of structural MCMV proteins, IE genes of MCMV specify target antigens for cytotoxic T cells (Reddehase & Koszinowski, 1984; Koszinowski et al., 1987) . While the expression of membrane IE gene products in vivo is unknown, the development of MCMV-specific cytotoxic T cells and antibodies to IE MCMV proteins may play a role in the maintenance of MCMV latency (Reddehase et al., 1986) .
In summary, the parameters that influence the profile of MCMV proteins recognized by murine antisera are also likely to contribute to the differences observed in the human antibody responses to HCMV proteins. The role these antibodies play individually or in combination towards recovery from MCMV infection and in the maintenance of latency is unknown, and studies to address this question employing monoclonal antibodies to a variety of MCMV polypeptides are in progress. Finally, our studies have shown the immunoblot assay to be a sensitive indicator of the development of the antibody response to MCMV. Thus, this technique may also be useful in the characterization and diagnosis of primary and recurrent HCMV infections.
